Institute of Medical Cell Technologies
- Research works
- 117 ▲ 62% vs 2013–17
- Citations
- 463 4.0 per fractional work
- Top-10% rate
- 4.3% record average 16.5%
- Open access
- 50% world 28%
Not ranked overall: Institute of Medical Cell Technologies is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 3.5×. Every wedge is a field page.
- Immunology and Microbiology 3.5×
- Biochemistry, Genetics and Molecular Biology 3.0×
- Medicine 2.8×
- Pharmacology, Toxicology and Pharmaceutics 1.7×
- Neuroscience 1.5×
- Materials Science 1.1×
- Chemistry 0.9×
- Engineering 0.7×
- Agricultural and Biological Sciences 0.6×
- Physics and Astronomy 0.5×
- Energy 0.4×
- Decision Sciences 0.4×
- Health Professions 0.2×
- Computer Science 0.1×
- Social Sciences 0.1×
- Environmental Science 0.1×
Who are the top researchers at Institute of Medical Cell Technologies?
Ranked on the composite score, Grigory Tsaur lead among researchers whose main affiliation is Institute of Medical Cell Technologies.
- 1 Grigory Tsaur Russia · #1,407,014 worldwide 2 citations · 18 works
Which keywords describe research at Institute of Medical Cell Technologies?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Prognostic Factors, Immunotherapy, Genetic Mutations, Regenerative Medicine, Precision Medicine, Stem Cell Therapy, Regeneration and Extracellular Matrix.
- Machine Learning
- Hematopoietic Stem Cells
- Acute Lymphoblastic Leukemia
- Public Health
- Neuroblastoma
- Differentiation
- Biomedical Applications
- Tissue Engineering
- Metabolic Syndrome
- Angiogenesis
- Mesenchymal Stem Cells
- Regeneration
- Extracellular Matrix
- Stem Cell Therapy
- Precision Medicine
- Oxidative Stress
- Immunotherapy
- Prognostic Factors
- Genetic Mutations
- Regenerative Medicine
- Inflammation
- Epidemiology
- Radiotherapy
- Cancer
- Staging System
- Energy Efficiency
- Minimal Residual Disease
- ALK
- Decellularization
- Glioblastoma
- Organ Engineering
- Temozolomide
- Childhood Cancer
- Immunomodulation
- Multipotent
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 35 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 35 words, with their numbers
- Prognostic Factors3▲ 18×10 topics
- Immunotherapy3▲ 11×6 topics
- Genetic Mutations2▲ 12×4 topics
- Oxidative Stress2▲ 3.3×12 topics
- Regenerative Medicine2▲ 20×4 topics
- Precision Medicine2▲ 9.4×6 topics
- Inflammation2▲ 2.0×8 topics
- Stem Cell Therapy2▲ 46×2 topics
- Epidemiology2◆ 0.94×10 topics
- Extracellular Matrix2▲ 21×4 topics
- Radiotherapy2▲ 9.4×3 topics
- Regeneration2▲ 19×3 topics
- Cancer1▲ 2.5×9 topics
- Mesenchymal Stem Cells1▲ 32×2 topics
- Staging System1▲ 57×2 topics
- Angiogenesis1▲ 9.3×4 topics
- Energy Efficiency1▲ 3.4×3 topics
- Metabolic Syndrome1▲ 3.8×5 topics
- Minimal Residual Disease1▲ 46×2 topics
- Tissue Engineering1▲ 5.2×5 topics
- ALK1▲ 117×1 topic
- Biomedical Applications1▲ 2.4×7 topics
- Decellularization1▲ 91×1 topic
- Differentiation1▲ 47×2 topics
- Glioblastoma1▲ 41×1 topic
- Neuroblastoma1▲ 117×1 topic
- Organ Engineering1▲ 91×1 topic
- Public Health1▲ 1.93×2 topics
- Temozolomide1▲ 41×1 topic
- Acute Lymphoblastic Leukemia1▲ 82×1 topic
- Childhood Cancer1▲ 82×1 topic
- Hematopoietic Stem Cells1▲ 29×2 topics
- Immunomodulation1▲ 20×1 topic
- Machine Learning1▼ 0.80×5 topics
- Multipotent1▲ 74×1 topic
Which research topics does Institute of Medical Cell Technologies publish most on?
By volume in 2022–2025: Tissue Engineering and Regenerative Medicine, Glioma Diagnosis and Treatment, Neuroblastoma Research and Treatments and Mesenchymal stem cell research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Tissue Engineering and Regenerative Medicine Surgery 1 works
- 2 Glioma Diagnosis and Treatment Genetics 1 works
- 3 Neuroblastoma Research and Treatments Neurology 1 works
- 4 Mesenchymal stem cell research Genetics 1 works
- 5 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 1 works
- 6 Nutrition, Genetics, and Disease Genetics 1 works
- 7 Iron and Steelmaking Processes Mechanical Engineering 1 works
- 8 Acute Myeloid Leukemia Research Hematology 1 works
- 9 Liver physiology and pathology Hepatology 1 works
- 10 Immunotherapy and Immune Responses Immunology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Institute of Medical Cell Technologies's research output changed?
Output in 2018–2022 was 62% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Yekaterinburg
- Ural Federal University
- Ural Branch of the Russian Academy of Sciences
- M.N. Mikheev Institute of Metal Physics
- Institute of Metallurgy
- Institute of History and Archaeology
- Russian School of Private Law
- Ural State University of Economics
- Institute of Engineering Science
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.